Corvus Pharmaceuticals Inc.

(CRVS) Trade

By |

Profile

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer.

Contact Information

Website: www.corvuspharma.com
Email: JColoma@corvuspharma.com
Main Phone: +1 650 900-4520
Address: 863 Mitten Road
Address 2: Suite 102
State: CA
City / Town: Burlingame
Country: USA
Postal Code: 94010

Issuer Information

Exchange: NSD
CEO: Richard A. Miller
Employees: 55
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small molecule and antibody agents that target the immune system to treat patients with cancer.

Contact Information

Website: www.corvuspharma.com
Email: JColoma@corvuspharma.com
Main Phone: +1 650 900-4520
Address: 863 Mitten Road
Address 2: Suite 102
State: CA
City / Town: Burlingame
Country: USA
Postal Code: 94010

Issuer Information

Exchange: NSD
CEO: Richard A. Miller
Employees: 55
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.12 $ 0.08 (1.98%)
Last Price 4.12 Change $ 0.08 Change % 1.98 Tick N/A
Bid 3.58 Bid Size 500.00 Ask 4.43 Ask Size 1,500.00
Open 4.06 High 4.19 Low 4.02 Prev Close 4.04
Last Trade Volume 51,754 52 Wk Hi 13.91 52 Wk Low 3.22
Market Cap 120.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 29,282,086.00 EPS (TTM) -1.97 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 8
Number of Buys 0 8
Number of Sells 0 0
Net Activity 0 1286470
Last 10 Buys Shares
Richard A. Miller 1,000
Elisha P. Gould 1,000
Elisha P. Gould 1,000
Elisha P. Gould 1,000
Elisha P. Gould 1,000
Elisha P. Gould 1,000
Peter A. Thompson 1,000
Richard A. Miller 1,000
Peter A. Thompson 1,000
Peter A. Thompson 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 25 25 25 25
Low Target Price Estimate 17 19 19 17
Mean Target Price Estimate 20.33 22 22 20.33
Standard Deviation 4.16 4.24 4.24 4.16
Date of Most Recent Estimate 06/05/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1